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Septic shock (SS)-related multiorgan dysfunction has been associated with oxidative damage, but little is known about the
temporal damage proﬁle and its relationship to severity. The present work investigated prospectively 21 SS patients. Blood samples
were obtained at diagnosis, 24, 72 hours, day 7, and at 3 months. At admission, thiobarbituric acid reactive substances (TBARSs),
plasma protein carbonyls, plasma protein methionine sulfoxide (MS), ferric/reducing antioxidant power (FRAP), total red blood
cell glutathione (RBCG), uric acid (UA), and bilirrubin levels were increased (P<. 05). Total radical—trapping antioxidant
potential (TRAP) and vitamin-E were similar to controls, and vitamin-C was decreased (P<. 05). During evolution, TBARS
and RBCG increased (P<. 001), vitamin-E levels remained stable, whereas plasma protein carbonyls and MS, TRAP, vitamin-C,
reduced glutathione, and UA levels decreased (P<. 006). After 3 months, plasma protein carbonyls and MS persisted elevated.
More severe patients exhibited higher TBARS, TRAP, FRAP, vitamin-C, UA, and bilirrubin levels. Our results suggest early and
persistent oxidative stress during septic shock and a correlation between increasing levels of lipoperoxidation and sepsis severity.
Copyright © 2008 Max Andresen et al.Thisisanopenaccess articledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Inﬂammation, sepsis, and particularly septic shock are
associated with global and local hypo-perfusion, ischemia-
reperfusion events, endothelial injury with an associated
procoagulant state, and monocyte—macrophage system
activation. All these processes contribute to the production
and release of diﬀerent cytokines and other inﬂammatory
mediators [1]. They also induce the production of large
amounts of free radicals in a nonregulated fashion associated
with high-oxidative potential damage [2]. In fact, several
s o u r c e so fr e a c t i v eo x y g e ns p e c i e s( R O S )h a v eb e e nd e t e c t e d
in sepsis and septic shock, including the mitochondrial res-
piratoryelectrontransportchain,immunecell,andxanthine
oxidaseactivationasaresultofischemiaandreperfusionand
the respiratory burst associated with NADPH oxidase [3].
Several studies have shown the presence of oxidative
stress in sepsis [4–9]. Early production of reactive oxygen
species (ROS) has been demonstrated in experimental stud-
i e si ns e p s i s[ 10], and excessive release of superoxide anion
has been shown to contribute to postreperfusion oxidative
damage in several ischemic organs [11, 12]. Increased
thiobarbituric acid reactive substances (TBARSs), which is a
marker of lipoperoxidation, has been observed in critically
ill patients in association with multiorgan failure (MOF)
development [7, 13].
Most studies about oxidative stress in sepsis have looked
at a single time-point, usually at admission. In addition,
very few of these studies have looked speciﬁcally at septic
shock patients [14, 15]. But septic shock has distinctive
features which may diﬀer substantially from less severe
forms of sepsis. It has a very dynamic course with several
changes taking place simultaneously in just a few hours.
Therefore, more comprehensive studies looking at the tem-
poral evolution of oxidative stress in septic shock patients
are required. This is a critical step to deﬁne windows of
opportunity for interventions aimed at modulating this
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Our main objective was to evaluate broadly the temporal
proﬁle of antioxidants and oxidative damage during septic
shock evolution. Secondary objectives were to determine if
oxidative damage markers and antioxidant levels are related
tosepticshockseverityandtoevaluatemethioninesulfoxide,
a novel marker of protein oxidative damage.
2. MATERIAL AND METHODS
This was a prospective observational study that included
patients with diagnosis of septic shock admitted to a
medical-surgical ICU of a university hospital from May 2004
to August 2005. The study was approved by the Ethical
Committee of the Facultad de Medicina of the Pontiﬁcia
Universidad Cat´ olica de Chile, Santiago, Chile, and an
informed consent was obtained from all patients or their
relatives.
2.1. Patientsandmanagement
Patients were enrolled if they fulﬁlled the following criteria:
(1) diagnosis of septic shock according to the consensus con-
ference[16],(2)lessthan24hourselapsedsinceadmissionto
the emergency department, and (3) age older than 18 years.
Exclusion criteria were (1) patients extremely ill, in whom
survival interval was expected to be less than 48 hours, (2)
use of any external vitamin supplement within one week
before enrollment, (3) onco-hematological, and (4) chronic
renalfailurepatients.Allpatientsweremanagedaccordingto
a standard hemodynamic and respiratory algorithm [17].
2.2. Datacollection
Demographic data, diagnosis, the acute physiology and
chronic health evaluation (APACHE) II score, sepsis-related
organ failure assessment (SOFA) score, hemodynamic and
respiratory parameters, maximal vasoactive drug dose, gen-
eral biochemistry (renal, hematological, and hepatic func-
t i o n ) ,a n dCr e a c t i v ep r o t e i n( C P R )l e v e l sw e r er e g i s t e r e da t
admission, 24 and 72 hours, as well as the seventh day of
evolution.
2.3. Oxidativestressevaluation
Oxidative stress markers employed were thiobarbituric acid
reactivesubstances(TBARSs),anindexoflipidperoxidation,
plus carbonyls, and methionine sulfoxide in plasma proteins
as markers of protein oxidative damage. Antioxidant activity
was evaluated by measuring: (a) total antioxidant capacity
(TAC) determined with two methods: (1) total radical- trap-
ping antioxidant potential (TRAP) and (2) ferric/reducing
antioxidant power (FRAP); (b) nonenzymatic antioxidants:
vitamins C and E, beta carotene, and lycopene; (c) enzymatic
antioxidant cofactors: reduced and total red blood cell
glutathione; and (d) nonspeciﬁc antioxidants: uric acid,
bilirubin, and albumin. Blood samples were obtained at
diagnosis (T0), 24 hours (T1), 72 hours (T3), and at the
seventh day of evolution (T7). Delayed measurements were
made in all survivors 3 months later. Normal values for
each parameter were obtained from a group of 17 healthy
volunteers matched for age and sex with septic shock
patients.
2.4. Laboratorytechnique
All samples were stored at −20◦C and were analyzed within
10 days, but for glutathione analysis, samples were stored
with ACD at 4◦C and were also analyzed within 10 days.
2.4.1. Totalantioxidantcapacity(TAC)
TRAP(total-trappingradical[Peroxyl]antioxidantpotential)
One mL of a mixture of Luminol (60μM)-AAPH (10mM),
in glycine buﬀer 50mM pH: 9.40, kept in ice and darkness,
was preincubated at 37◦C. This mixture was poured into a
cuvette of polystyrene (Clinicon) and placed in a luminome-
ter (BioOrbit 1250, Finland) kept at 37◦C. When the light
emissionreachedasteady-statecondition,10μLofplasmaor
standard (Trolox) were added. The luminescence was plotted
against the elapsed time. The induction time (tsample) was
equated to the time required for the chemiluminescence
intensity to reach a level equal to 40% of the intensity
measured prior to the sample addition [18]. The quenching
of thelight emissionwasrecordedina Kipp &Zonen BD111
recorder. The coeﬃcient of variation for this measurement is
4, 04%.
FRAP(ferric/reducingantioxidantpower)
Reduction at low pH of a ferric tripyridyltriazine (FeIII-
TPTZ) complex to the ferrous form, by electron-donating
antioxidants [19]. Samples were incubated in mixture of
TPTZ, FeCl3,a n da c e t a t eb u ﬀer (1:1:10) for 5 minutes at
37◦Ca n dq u a n t i ﬁ e da t5 9 3n m .T h ec o e ﬃcient of variation
for this measurement is 2,5%.
2.4.2. VitaminE(α-tocopherol),β-carotene,andlycopene
Lipidsolubleantioxidantconcentrationsweredeterminedby
HPLC with electrochemical detection [20]. Plasma samples
were precipitated with methanol and extracted with hexane
and centrifuged. The organic phase was dried, and the
residue was redissolved in methanol: ethanol. An isocratic
phase reverse chromatography was performed using a Supel-
cosil C-8 column, and 20mM LiClO4 in methanol: H2O
(97.5:2.5) as mobile phase. For electrochemical detection,
an amperometric BAS LC4C detector (Bioanalytical Systems
Inc., West Lafayette, Ind, USA) was used with an applied
potential of +0.6V. The coeﬃcient of variation for vitamin
Ei s1 ,8 % ,f o rβ-carotene is 9,3%, and for lycopene is 8,2%.
2.4.3. Ascorbicacid
Determinations were carried out by a method based
on the reduction of ferric chloride by ascorbic acid,
with the resulting ferrous ion quantiﬁed by the addition
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samples were precipitated with trichloroacetic acid. The
tubes were centrifuged at 20,800g for 30 seconds. An aliquot
from the supernatant was incubated with TPTZ and FeCl3
in buﬀer acetate for 5 minutes at 25◦C, and quantiﬁed at
595nm. The coeﬃcient of variation for this measurement is
3,4%.
2.4.4. Glutathione
Totalredbloodcellglutathione
Red blood cells were lysed and precipitated by adding
perchloric acid 0.28M to fresh blood anticoagulated with
ACD. An aliquot from the supernatant, neutralized with
K3PO41.75M,wasincubatedwithphosphatebuﬀer0.1mM
(EDTA 1mM) and 5.5 -dithiobis (2-nitrobenzoic acid)
0.5mM (sodium Citrate 1% p/v) for 7 minutes at 25◦Ca n d
quantiﬁed at 412nm [22].
Reducedredbloodcellgluthatione
The cells were rinsed four times with 3mL of ice cold PBS.
Collected cells were diluted in phosphate buﬀer containing
diethylenetriaminepentaacetic acid 1.34mM pH 7.8. An
aliquot was derivatized by the addition of N-(1-pyrenyl)
maleimide 1.0mM in acetonitrile. Solutions were incubated
for 5 minutes at room temperature and then acidiﬁed with
HCl to pH 2.5. An isocratic phase reverse chromatography
was performed using a Supelcosil C-18 column and 65%
acetonitrile: 35% H2O, 1mL/liter acetic acid, and 1mL/liter
O-phosphoric acid as mobile phase. A ﬂuorescence spec-
trophotometer detector (Merck-Hitachi F-1000, Darznstadt,
Germany)wasusedfordetectionλex 330nmandλem 375nm
[23].
2.4.5. TBARS
The method is based on the formation of an adduct TBA-
MDA (2:1). Plasma samples, TBA solution (0.67%/NaOH
0.05N), and TCA 50% solution were placed in this order into
a screw-cap test tube and incubated at 90◦Cf o r4 5m i n u t e s .
The aqueous phase was quantiﬁed at 532nm. TBARS
plasmatic levels are expressed in micromolar equivalent
MDA [24].
2.4.6. Carbonyls
Plasma protein samples were reacted with dinitrophenyl-
hydrazine and then adsorbed to wells of an ELISA plate,
overnight at 4◦C, before probing with a commercial anti-
body raised against protein-conjugated DNP. The biotin-
conjugated primary antibody (anti-DNP Polyclonal IgG)
was then reacted with streptavidin-conjugated horseradish
peroxidase forquantiﬁcationwith TMB.Acidic stop solution
was added, and absorbance measured at 450nm. The
method was calibrated using oxidized and reduced albumin
[25]. The coeﬃcient of variation for this measurement is 16,
2%.
2.4.7. Methioninesulfoxide
Protein methionine sulfoxide content was measured by
HPLC-ﬂuorometric detection, using a modiﬁcation of the
method of Morgan et al. [26] and was expressed as
the fraction of total methionine oxidized to methion-
ine sulfoxide: proteins from 10μL plasma aliquots were
precipitated with 60μL of ice-cold acetonitrile and cen-
trifuged at 10000g for 20 minutes; the protein pellets were
hydrolyzed using methanesulfonic acid at 150◦Cf o r9 0
minutes and were derivatized with o-phthaldialdehyde/β-
mercaptoethanol solution. Derivatized amino acids were
detectedbyanHPLC-ﬂuorescencespectrophotometerdetec-
tor (Merck-Hitachi F-1000), λex 340nm, and λem 455nm,
and quantiﬁed using standards containing methionine,
methionine sulfoxide, and methionine sulfone. Analysis was
performed by reverse-phase HPLC using a Synergy 4μM
fusion column with a continuous gradient of mobile phase
75mM Na acetate buﬀer pH 4.5: methanol: tetrahydrofuran
(80:19:1) initial to (20:80:0) ﬁnal, in 40 minutes. The
coeﬃcient of variation for this measurement is 9.2%.
2.5. Statisticalanalysis
Changes along time for the diﬀerent oxidative stress markers
were analyzed with linear mixed eﬀects models. In addition,
measurements in septic shock patients at each time point
were compared with normal values from healthy matched
subjects by a t-test for independent samples (samples exhib-
ited a normal distribution). Correlations between severity
parameters and oxidative stress markers were made with
Pearson. Linear mixed eﬀects models, adjusted by sex and
age, were also used to conﬁrm the association between sever-
ity parameters and oxidative stress. Results are expressed as
mean ± SD, and a P<. 05 was considered signiﬁcant. The
proc MIXED of the SAS statistical program was used for
analysis.
3. RESULTS
Atotalof21patientsfulﬁlledinclusion/exclusioncriteriaand
were studied. Average age for all septic shock patients was 60
± 20 years, APACHE II and SOFA scores at admission were
22.5 ± 6.6a n d1 1± 4.2, respectively. The main causes of
septicshockwererespiratoryandabdominal.Only4patients
died (19%). Demographic characteristics of the patients are
summarized in Table 1.
3.1. Oxidativedamage
At admission, all septic shock patients presented evidence
of oxidative damage on lipids and proteins, measured either
by carbonyls or methionine sulfoxide (Figure 1). TBARS
levels were increased twofold at admission compared to
normal values and increased further during the ﬁrst week
of evolution (P<. 001) (Figure 1(a)). At 3 months, TBARS
levels had normalized in septic shock survivors. Oxidative
damageonproteinswasalsopresentatadmission.Carbonyls
were increased 4.5-fold and methionine sulfoxide 2.1-fold4 Mediators of Inﬂammation
Table 1: Characteristics of the patients.
Age (years) 60.2 ±20.7
Gender (female/male) 10/11
APACHE II score 22.5 ±6.6
SOFA score at admission (T0) 10.5 ±3.6
24 hours (T1) 9.7 ± 4
72 hours (T3) 7.5 ±4.7
7th day (T7) 5.5 ±6.8
Septic shock etiology (n (%))
Pneumonia 6 (35.3)
Abdominal 7 (29.4)
Urological 4 (11.8)
Others 4 (23.5)
C-Reactive protein levels at admission 23.5 ±10.4
Lactate levels at admission (mmol/l) 4.8 ± 3
Noradrenaline (Max. dose (ug/kg/min)) 0.31 ±0.2
ALI/ARDS (n (%)) 19 (88)
Mechanical ventilation (n (%)) 16 (70)
ALI/ARDS, Acute lung injury/Acute respiratory distress syndrome;
APACHE II score, Acute physiology and chronic health evaluation score II
on ICU admission; SOFA score, Sequential organ failure assessment.
Values reported are mean ± SD or n (%).
compared to normal values (Figures 1(b) and 1(c)). There-
after, both markers tended to decrease during the ﬁrst week
of evolution (P<. 01 for both), however they did not reach
normal levels, even after three months.
3.2. Antioxidantactivity
3.2.1. Totalantioxidantcapacity(TAC)
TAC measured by TRAP was normal at admission and day
1 (354 ± 123 versus 361 ± 50μM EqTlx for normal values),
but decreased after day 3 (246 ± 110μM EqTlx, P<. 001).
At three months, TRAP levels remained decreased (279 ±
48μM EqTlx, p<0.01). TAC levels measured by FRAP
were elevated at admission (1656 ± 498 versus 1120 ± 47μM
EqFe2+ for normal values, P<. 001) and remained increased
throughout the study period.
3.2.2. Individualantioxidants
Vitamin C, beta carotene, and lycopene levels were signif-
icantly decreased at admission and continued to decrease
progressively throughout the ﬁrst week of evolution (P<
.001) (Figure 2(a) for vitamin C). In contrast, vitamin E
levels remained normal at all time points (Figure 2(b)).
At 3 months, vitamin C and lycopene normal levels were
recovered, but not yet beta carotene.
Reduced glutathione levels were normal at admission,
but decreased after 24 hours and during the ﬁrst week
of evolution (P<. 001). In contrast, total red blood cell
glutathione levels were increased three-fold at admission and
signiﬁcantlyincreasedduringtheﬁrstweekofevolution(P<
.001). At 3 months, both parameters had returned to normal
values (Figure 2(c)).
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Figure 1: Temporal evolution of oxidative damage of all septic
shock patients in (a) lipoperoxidation (TBARS), (b) carbonyls, and
(c) Methionine sulfoxide. Normal values (mean ± SD) obtained
from matched healthy subjects are shown as continuous and dotted
lines, respectively. p: reﬂects variation in time calculated by linear
mixed eﬀects model. ∗Indicates signiﬁcant diﬀerences between
normal values and patients at diﬀerent time points (t-test for
independent samples).
Uric acid levels were increased at admission (6.7 ± 2.3
versus 5 ± 0.5mg/dL for normal values, P<. 01), but
returnedprogressivelytonormalvalueswithintheﬁrstweek.
Bilirubin levels were also increased at admission (2.3 ± 2.1
versus 0.8 ± 0.5mg/dL for normal values, P<. 001) and did
not change during evolution. A positive correlation betweenMax Andresen et al. 5
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Figure 2: Evolution of antioxidant levels in all septic shock patients
of (a) Vitamin C, (b) Vitamin E (alpha-Tocopherol), and (c)
reduced and oxidized glutathione. Normal values (mean ± SD)
obtained from matched healthy subjects are shown as continuous
and dotted lines, respectively. p: reﬂects variation in time calculated
by linear mixed eﬀects model. ∗Indicates signiﬁcant diﬀerences
between normal values and patients at diﬀerent time points (t-test
for independent samples).
uric acid levels and TRAP and FRAP levels was observed (r:
0.83 and 0.47, resp., P<. 03 for both) (Figure 3) and also
betweenbilirrubinlevelsandFRAPlevels(r:0.75,P<. 4with
FRAP, P<. 001).
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Figure 3: Correlations of peak FRAP and TRAP levels with peak
uric acid levels. P<. 05 for both correlations exposed.
3.3. Oxidativestressandseverityscores
SOFA scores decreased signiﬁcantly along time in survivors,
mainly due to a rapid decrease in cardiovascular and respi-
ratory components of SOFA scores. Patients who died had
higher levels of APACHE II and SOFA scores at admission
and peak and also had higher lactate levels and peak doses of
vasoactive drugs (P<. 05 for all). C-reactive protein (CRP)
levels were elevated at admission (23.5 ± 10.4 mg/dL versus
0.6 ± 0.3f o rn o r m a lv a l u e s ,P<. 001) and decreased during
septic shock evolution, but persisted still elevated at day 7.
Their levels were normal at 3 months.
3.4. Atadmission
A positive correlation of admission SOFA score with FRAP
(Figure 4), vitamin C, and uric acid admission levels was
observed (r:0.63, r:0.48, and r:0.48, resp., P<. 05 for
all). APACHE II score was correlated with FRAP, TRAP,
B-carotene, and uric acid admission levels (r:0.5, r:0.6,
r:0.5, and r:0.56, resp., P<. 05 for all), whereas lactate
admission levels were correlated with FRAP (Figure 4)a n d
bilirubinadmissionlevels(r:0.48and0.64,P<. 05forboth).
A negative correlation was observed between oxygenation
(PaO2/FiO2 ratio) and FRAP, TRAP, vitamin C, and uric
acid levels at admission (r:−0.44, r:−0.68, r:−0.58, and
r:−0.48, resp., P<. 05 for all). No signiﬁcant correlations
wereobservedbetweenlipidorproteinoxidativedamageand
severity of illness at admission.
3.5. Duringtheevolutionofshock
TBARS peak levels exhibited a positive correlation with peak
SOFA score and peak lactate levels (r:0.52andr:0.46, P<
.05 for both) (Figure 5(a)). TBARS peak levels were also
positively correlated with peak FRAP (r:0.57, P<. 05). No
correlations or associations were observed between protein
oxidative damage and antioxidant consumption or severity
of disease at admission or during septic shock evolution.6 Mediators of Inﬂammation
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Figure 4: Admission correlations of peak SOFA score and peak
lactate levels with peak FRAP levels. P<. 05 for the correlation
exposed.
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Figure 5: Evolution correlations of peak SOFA score and peak
lactate levels with (a) peak TBARS levels and (b) peak FRAP levels.
P<. 05 for all correlations exposed.
Peak SOFA score was also correlated with peak levels of
FRAP (Figure 5(b)), TRAP, bilirubin, and vitamin C levels
(r:0.82, r:0.82, r:0.6, and r:0.56, resp., P<. 05 for all).
APACHE II score was correlated with peak levels of FRAP,
TRAP, uric acid, and vitamin C levels (r:0.67, r:0.66, r:0.45,
and r:0.6, resp., P<. 05 for all). Peak lactate levels were
correlated with FRAP (Figure 5(b)) and bilirubin peak levels
(r:0.66 and r:0.65, P<. 05 for both). All correlations
presented above were conﬁrmed as positive associations by
linear mixed eﬀects model in time.
4. DISCUSSION
Our study prospectively evaluated the temporal proﬁle of
antioxidants and oxidative damage markers during the ﬁrst
week of evolution of septic shock and their correlation with
severity. We found evidence of early oxidative damage on
proteins and lipids associated with severe vitamin C, β-
carotene, lycopene, and reduced glutathione depletion, but
not associated with reduced TAC or vitamin E levels. Early
production of reactive oxygen species has been documented
in endotoxin models [14], and clinical studies also have
found that critical care patients already present evidence
of oxidative stress at admission [2, 7–9, 27, 28]. Therefore,
oxidative damage is a rather early phenomenon of the
systemic inﬂammatory response, including septic shock,
taking place even before septic patients arrive to critical care
units. This notion may in part explain why interventions
which have been shown to be eﬀective to prevent oxidation
[29]m a yn o tb ee ﬀective to revert an already established
oxidative damage in the ICU setting.
Wealsofoundthatlipoperoxidationincreasesalongtime.
This may be the result of an initial insult, most probably
ischemic, followed by an independent perpetuating process,
which could be explained by the autocatalytic nature of the
lipoperoxidation cascade, by persistent immune activation,
by continuous episodes of reperfusion, or by insuﬃcient
or ineﬀective antioxidation. Protein oxidative damage, in
contrast, signiﬁcantly decreases along time in parallel with
the decrease of SOFA score. Decreasing levels of protein
oxidative damage have been described before [30] and since
we expressed protein oxidative markers as a proportion of
total plasma proteins, changes in carbonyls and methionine
sulfoxide levels should not be inﬂuenced by changes in
total body proteins in our study and may truly reﬂect that
protein oxidative damage is maximal early in the septic
process.
Lipoperoxidation was positively correlated to septic
shock severity and to organ dysfunction estimated by
SOFA, suggesting that oxidative damage may have a role
in the development of multiorgan dysfunction. Recently,
Motoyama et al. [8] in SIRS patients also found that higher
levels of TBARS at admission and in time were associated
with the development of multiorgan failure (MOF). In
contrast, we did not ﬁnd any signiﬁcant correlation between
protein oxidative damage and septic shock severity at any
timepoint.Sinceseveralcriticalproteinshavebeendescribed
tobepartiallyorcompletelyinactivatedbytheactionofreac-
tive oxygen species during sepsis, suggesting that oxidativeMax Andresen et al. 7
damage over proteins could have a role in sepsis [31, 32], it is
possible that carbonyls and methionine sulfoxide, although
sensitive markers of protein damage [33, 34], do not reﬂect
the real impact of oxidative stress over critical proteins and
enzymes.
TAC levels exhibited diﬀerent kinetics along time accord-
ing to the method used to estimate them. These diﬀerences
could be explained looking at the individual contributors
to serum TAC levels, which are represented in diﬀerent
proportions according to the method used to estimate
TAC. Particularly in septic shock, TRAP levels are strongly
inﬂuenced by uric acid levels (r:0.83), explaining the parallel
decreaseofbothmarkersalongtime.Incontrast,FRAPlevels
are less dependent on uric acid, but may be also inﬂuenced
by bilirubin and other nonidentiﬁed compounds, which
may explain the increase in FRAP levels at admission and
during the study period [35]. Both parameters, TRAP and
FRAP and their major contributors, uric acid and bilirubin,
werepositivelycorrelatedwithsepticshockseverity.Previous
studies have already suggested that TAC levels may be higher
in more severe forms of sepsis [15, 35, 36]. In particular,
elevations of uric acid during sepsis can be explained by an
increase in uric acid production associated with activation
of Xantine oxidase (XO) in ischemic territories during sepsis
and septic shock [2].
Vitamin C levels were below normal values during the
study period, probably explained by ongoing consumption.
Although we expected to observe larger consumption in the
most severe patients, we found the opposite; more severe
septic patients had higher vitamin C levels. We speculate
that lower consumption of vitamin C observed in most
severe patients might be explained by larger availability of
other nonenzymatic antioxidants in these patients, namely,
uric acid and bilirubin, both of which may act as eﬀective
antioxidants in plasma [37, 38]. Interestingly, even though
most severe patients exhibited higher TAC and vitamin C
levels, these were also positively correlated to peak TBARS
indicating that lipoperoxidation may occur despite normal
or even increased antioxidant capacity.
At 3 months, lipoperoxidation levels normalized in
septic shock survivors, whereas protein oxidative markers
still remained elevated. Persistent elevation of carbonyls
and methionine sulfoxide is diﬃcult to explain. Ongoing
oxidative stress is unlikely since CRP levels were normal at
three months, and most patients were already doing well at
home. A slow protein turnover would explain that 3 months
wereinsuﬃcienttoreachnormallevelsofthesemarkers[34].
This ﬁnding suggests that these indexes could be used as
markers of a previous oxidative stress situation.
A limitation of our study was the exclusion of some
patients that were extremely ill and were expected to die
before 48 hours, patients admitted from the ward and
chronic renal failure patients. These patients may present a
diﬀerent antioxidant—oxidative scenario. However, during
the study period, from all consecutive septic shock patients
admitted to our unit only 5 were excluded. These exclusion
criteria may partially explain the 19% mortality, which is
lowerthanpredictedfromSOFAandAPACHE IIscores.Our
reported mortality for septic shock is 33% [17].
5. CONCLUSIONS
Our study shows early and persistent oxidative stress dur-
ing septic shock, reﬂected on lipid and protein damage
and on nonenzymatic antioxidant apparent consumption.
Protein oxidation reaches its peak early at admission, but
lipoperoxidation continues to increase during the ﬁrst
days of evolution. More severe patients exhibit higher
levels of lipoperoxidation but also higher levels of total
antioxidant capacity, uric acid, bilirubin, and vitamin C.
We showed for the ﬁrst time that methionine sulfoxide
levels are increased in septic shock patients and, therefore,
may be used as a sensitive marker of protein oxidation in
sepsis.
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